iSAM Funds UK Ltd Buys New Shares in Cabot Co. (NYSE:CBT)

iSAM Funds UK Ltd bought a new stake in shares of Cabot Co. (NYSE:CBT - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 5,820 shares of the specialty chemicals company's stock, valued at approximately $531,000.

Several other large investors have also recently bought and sold shares of the stock. R Squared Ltd acquired a new position in shares of Cabot in the 4th quarter valued at $26,000. EverSource Wealth Advisors LLC raised its stake in shares of Cabot by 37.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock valued at $74,000 after buying an additional 219 shares in the last quarter. Manchester Capital Management LLC raised its stake in shares of Cabot by 1,685.1% in the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock valued at $153,000 after buying an additional 1,584 shares in the last quarter. KBC Group NV raised its stake in shares of Cabot by 43.1% in the 4th quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock valued at $187,000 after buying an additional 616 shares in the last quarter. Finally, Measured Wealth Private Client Group LLC acquired a new position in shares of Cabot in the 4th quarter valued at $205,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Trading Down 1.1%

Shares of Cabot stock opened at $75.76 on Tuesday. The stock has a market capitalization of $4.07 billion, a P/E ratio of 10.06, a price-to-earnings-growth ratio of 0.74 and a beta of 0.91. The company has a quick ratio of 1.29, a current ratio of 2.00 and a debt-to-equity ratio of 0.72. The company has a 50-day simple moving average of $79.18 and a 200 day simple moving average of $89.61. Cabot Co. has a 12-month low of $71.64 and a 12-month high of $117.46.

Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.86 by $0.04. The business had revenue of $936.00 million during the quarter, compared to analysts' expectations of $1.02 billion. Cabot had a net margin of 10.60% and a return on equity of 26.79%. The firm's revenue for the quarter was down 8.1% on a year-over-year basis. During the same quarter last year, the company posted $1.78 EPS. Research analysts expect that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Cabot Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 30th will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.38%. The ex-dividend date is Friday, May 30th. This is a boost from Cabot's previous quarterly dividend of $0.43. Cabot's dividend payout ratio (DPR) is presently 23.29%.

Wall Street Analyst Weigh In

CBT has been the subject of a number of recent research reports. StockNews.com cut shares of Cabot from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. UBS Group dropped their price objective on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research note on Monday, April 7th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research report on Friday, February 21st.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.